This study [119] has shown that the levels of ALCAM in primary tumours and metastatic tumours correlated exceptionally well (r2 = 0.504, p < 0.001) and that metastatic tumours in different sites (liver, lung, bone, brain, and lymph nodes) stained reasonably similar to primary tumours. Here, ALCAM is linked to metastatic neoplasm.